000 | nab a22 7a 4500 | ||
---|---|---|---|
999 |
_c17466 _d17466 |
||
003 | PC17466 | ||
005 | 20230519134615.0 | ||
008 | 230519b xxu||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aspa, eng | ||
100 |
_9891 _aVanaclocha Sebastián, Francisco _eDermatología Médico Quirúrgica y Venereología |
||
245 | 0 | 0 |
_aIncidencia a los 2 años de psoriasis, uveítis y enfermedad inflamatoria intestinal en la cohorte de pacientes con espondiloartritis del estudio AQUILES. _h[artículo] |
260 |
_bReumatología clínica, _c2016 |
||
300 | _a12(1):22-6. | ||
500 | _aFormato Vancouver: García Vicuña R, Zarco P, González CM, Vanaclocha F, Marín Jiménez I, Cea Calvo L. Incidencia a los 2 años de psoriasis, uveítis y enfermedad inflamatoria intestinal en la cohorte de pacientes con espondiloartritis del estudio AQUILES. Reumatol Clin. 2016 Jan-Feb;12(1):22-6. | ||
501 | _aPMID: 25683367 | ||
504 | _aContiene 27 referencias | ||
520 | _aObjectives: To describe the 2-year incidence of new extra-articular manifestations (uveitis, psoriasis, inflammatory bowel disease) in a cohort of patients with spondyloarthritis included in the AQUILES study. Patients: Over a period of 2 years, 513 patients with spondyloarthritis (62.5% males, mean age 48 years) diagnosed with ankylosing spondylitis (AS) (55.6%), psoriatic arthritis (25.3%), undifferentiated spondyloarthritis (16.2%), enteropathic arthritis (2.5%), and other diseases (0.4%) were followed. New diagnoses were based on reports of the corresponding specialists (ophthalmologists, dermatologists, gastroenterologists). Results: During the 2-year follow-up, 22 new diagnoses of the extra-articular manifestations were established, with a cumulative incidence of 4.3% (95% confidence interval 2.4-6.1) and an incidence rate of 17 cases per 10,000 patient-year. Uveitis was the most frequent diagnosis (cumulative incidence 3.1%), predominantly in patients with AS. In the multivariate analysis, the diagnosis of AS was the only predictive variable associated to the development of new extra-articular disease. Conclusions: In patients with spondyloarthritis, the 2-year global incidence of uveitis, psoriasis and inflammatory bowel disease (IMID) was 4.3%, particularly due to new diagnoses of uveitis in patients with AS. | ||
710 |
_9145 _aServicio de Dermatología Médico-Quirúrgica y Venereología |
||
856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc17466.pdf _ySolicitar documento |
||
942 |
_2ddc _cART _n0 |